| In millions, except per share items | Sep-30-16 | Jun-30-16 | Mar-31-16 | Dec-31-15 | Sep-30-15 | Jun-30-15 | Mar-31-15 | Dec-31-14 |
| | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
| Operating Activities | | | | | | | | |
| Net loss | -1.4 | 2.0 | -1.8 | -9.2 | -9.0 | -9.3 | -10.6 | -9.6 |
| |
| Adjustments to reconcile net loss to net cash used in operating activities: | | | | | | | | |
| Depreciation and amortization of equipment and improvements | 0.3 | 0.3 | 0.2 | | 0.2 | 0.3 | 0.3 | |
| Amortization of Intangible Assets | 1.2 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.8 |
| Provision for bad debts | 0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 |
| Allowance for sales adjustments | 1.4 | 0.1 | -0.1 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 |
| Provision for inventory obsolescence | 0.0 | 0.3 | 0.1 | 0.6 | -0.1 | 0.0 | -0.1 | -0.1 |
| Deferred rent | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | 0.0 | |
| Stock-based compensation | 0.4 | 0.6 | 0.7 | 0.7 | 1.2 | 1.3 | 1.6 | 0.8 |
| Deferred income taxes | -0.7 | 0.4 | -0.4 | -1.8 | -1.3 | 0.3 | 0.0 | 0.1 |
| Change in fair value of contingent consideration | 0.4 | | | | | | | |
| Gain on sale of investment | | -4.7 | | | | | | |
| Loss on disposal of equipment | 0.0 | 0.0 | 0.0 | | | | | |
| Gain on sale of FAD business | -3.8 | | | | | | | |
| Changes in operating assets and liabilities: | | | | | | | | |
| Accounts receivable | 0.9 | -1.2 | 0.0 | 0.5 | 0.4 | -1.0 | 0.4 | -1.2 |
| Notes receivable | 0.9 | -1.2 | 0.0 | 0.5 | 0.4 | -1.0 | 0.4 | -1.2 |
| Inventories | 1.4 | 2.7 | -0.2 | -3.3 | -1.2 | -1.6 | -3.0 | 1.6 |
| Prepaid expenses and other assets | -0.6 | 0.5 | 0.0 | 0.2 | -0.1 | 1.5 | 0.1 | -0.4 |
| Accounts payable | 0.0 | -0.4 | -0.5 | -1.3 | -1.6 | 0.0 | 1.3 | -0.7 |
| Accrued expenses and other liabilities | 0.2 | -1.8 | -2.7 | 4.6 | 1.8 | -0.2 | -1.6 | 1.0 |
| Net cash used in operating activities | -0.2 | -0.6 | -3.7 | -8.1 | -8.8 | -7.8 | -10.7 | -7.1 |
| |
| Investing Activities | | | | | | | | |
| Acquisition of a business, net of cash acquired | -13.5 | | | | | | | |
| Proceeds from sale of FAD business, net of transaction costs | 9.5 | | | | | | | |
| Proceeds of note receivable | 0.2 | | | | | | | |
| Purchase of investments | | -5.0 | -30.0 | -10.0 | -10.0 | -15.0 | -20.0 | -31.5 |
| Proceeds from sale of investments | 10.0 | 12.6 | 30.0 | 20.0 | 20.0 | 20.0 | 26.0 | 15.2 |
| Purchase of equipment and improvements | -0.1 | -0.1 | -0.1 | -0.7 | -0.2 | -0.5 | -0.4 | -0.6 |
| Net cash provided by investing activities | 6.2 | 7.5 | -0.1 | 9.3 | 9.8 | 4.5 | 5.6 | -16.7 |
| |
| Financing Activities | | | | | | | | |
| Line of credit payment | -1.4 | | | | | | | |
| Proceeds fro m issuance of common stock, net of issuance costs | 2.2 | | | | 2.0 | | | |
| Payment of withholding taxes related to employee stock-based compensation | | | 0.0 | -0.1 | | | -0.1 | -0.2 |
| Net cash provided by financing activities | 0.8 | 0.0 | 0.0 | -0.1 | | 0.1 | 1.8 | -0.2 |
| |
| Effect of exchange rate changes on cash and cash equivalents | 0.2 | 0.3 | -0.2 | 0.3 | 0.4 | -0.3 | 0.4 | 0.1 |
| Net increase (decrease) in cash and cash equivalents | 7.0 | 7.2 | -4.0 | 1.4 | 1.4 | -3.5 | -2.9 | -23.9 |
| |
| Cash and cash equivalents | | | | | | | | |
| Beginning of period | | | 15.8 | | | | 19.4 | |
| End of period | 7.0 | 7.2 | 11.8 | 1.4 | 1.4 | -3.5 | 16.5 | -23.9 |
| |
| Supplemental disclosures of cash flow information: | | | | | | | | |
| Non-cash investing and financing activities | | | | | | | | |
| Issuance of common stock | 9.2 | | | | | | | |
| Incurrence of contingent liabilities | 56.8 | | | | | | | |
| Total | 66.0 | | | | | | | |
| Receipt of note receivable as partial consideration in sale of FAD business | 2.7 | | | | | | | |
| Cash paid during the period for: | | | | | | | | |
| Taxes | 0.0 | 0.4 | | | | | | |